CTCF-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-149-5p to Up-Regulate CTCF and CTNNB1 to Activate Wnt/β-Catenin Pathway

REFERENCES

• Wang S, Ke H, Zhang H, Ma Y, Ao L, Zou L, Yang Q, Zhu H, Nie J, Wu C, Jiao B. 2018. LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci. Cell Death Dis 9:805. https://doi.org/10.1038/s41419-018-0869-2.
   PubMed Web of Science ®Google Scholar
• Luan X, Wang Y. 2018. LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p. J Gynecol Oncol 29:e95. https://doi.org/10.3802/jgo.2018.29.e95.
   PubMed Web of Science ®Google Scholar
• Xu S, Cui F, Huang D, Zhang D, Zhu A, Sun X, Cao Y, Ding S, Wang Y, Gao E, Zhang F. 2019. PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells. Int J Nanomedicine (Lond) 14:17–32. https://doi.org/10.2147/IJN.S175340.
   PubMed Web of Science ®Google Scholar
• Liang H, Huang W, Wang Y, Ding L, Zeng L. 2019. Overexpression of miR-146a-5p upregulates lncRNA HOTAIR in triple-negative breast cancer cells and predicts poor prognosis. Technol Cancer Res Treat 18:1533033819882949. https://doi.org/10.1177/1533033819882949.
   Web of Science ®Google Scholar
• Ransohoff JD, Wei Y, Khavari PA. 2018. The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol 19:143–157. https://doi.org/10.1038/nrm.2017.104.
   PubMed Web of Science ®Google Scholar
• Ni MW, Zhou J, Zhang YL, Zhou GM, Zhang SJ, Feng JG, Xu Q, Zhou Y, Mou HZ, Zheng ZG. 2019. Downregulation of LINC00515 in high-grade serous ovarian cancer and its relationship with platinum resistance. Biomark Med 13:535–543. https://doi.org/10.2217/bmm-2018-0382.
   PubMed Web of Science ®Google Scholar
• Zhu X, Niu X, Ge C. 2019. Inhibition of LINC00994 represses malignant behaviors of pancreatic cancer cells: interacting with miR-765-3p/RUNX2 axis. Cancer Biol Ther 20:799–811. https://doi.org/10.1080/15384047.2018.1564566.
   PubMed Web of Science ®Google Scholar
• Xu X, Lou Y, Tang J, Teng Y, Zhang Z, Yin Y, Zhuo H, Tan Z. 2019. The long non-coding RNA Linc-GALH promotes hepatocellular carcinoma metastasis via epigenetically regulating Gankyrin. Cell Death Dis 10:86. https://doi.org/10.1038/s41419-019-1348-0.
   PubMed Web of Science ®Google Scholar
• Luo DB, Lv HB, Sun XH, Wang Y, Chu JH, Salai AL. 2020. LncRNA TRERNA1 promotes malignant progression of NSCLC through targeting FOXL1. Eur Rev Med Pharmacol Sci 24:1233–1242. https://doi.org/10.26355/eurrev_202002_20176.
   PubMed Web of Science ®Google Scholar
• Lin H, Shen L, Lin Q, Dong C, Maswela B, Illahi GS, Wu X. 2020. SNHG5 enhances Paclitaxel sensitivity of ovarian cancer cells through sponging miR-23a. Biomed Pharmacother 123:109711. https://doi.org/10.1016/j.biopha.2019.109711.
   PubMed Web of Science ®Google Scholar
• Jia H, Liang K, Liu G, Zhang Z, Shi Y, Liang H, Liu P. 2020. lncRNA DANCR promotes proliferation and metastasis of breast cancer cells through sponging miR-4319 and upregulating VAPB. Cancer Biother Radiopharm. https://doi.org/10.1089/cbr.2020.3675.
   Google Scholar
• Rui X, Xu Y, Jiang X, Ye W, Huang Y, Jiang J. 2018. Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis. Cell Death Dis 9:1175. https://doi.org/10.1038/s41419-018-1228-z.
   PubMed Web of Science ®Google Scholar
• Correia de Sousa M, Gjorgjieva M, Dolicka D, Sobolewski C, Foti M. 2019. Deciphering miRNAs’ action through miRNA editing. Int J Mol Sci 20:6249. https://doi.org/10.3390/ijms20246249.
   PubMed Web of Science ®Google Scholar
• An Y, Yang Q. 2020. MiR-21 modulates the polarization of macrophages and increases the effects of M2 macrophages on promoting the chemoresistance of ovarian cancer. Life Sci 242:117162. https://doi.org/10.1016/j.lfs.2019.117162.
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhong H, Jiao L, Wen Y, Zhou Y, Zhou J, Lu X, Song X, Ying B. 2020. miR-124-3p inhibits the migration and invasion of Gastric cancer by targeting ITGB3. Pathol Res Pract 216:152762. https://doi.org/10.1016/j.prp.2019.152762.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li TE, Chen M, Pan JJ, Shen KW. 2020. miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway. Aging (Albany NY) 12:1867–1887. https://doi.org/10.18632/aging.102719.
   PubMedGoogle Scholar
• Qi X, Zhang DH, Wu N, Xiao JH, Wang X, Ma W. 2015. ceRNA in cancer: possible functions and clinical implications. J Med Genet 52:710–718. https://doi.org/10.1136/jmedgenet-2015-103334.
   PubMed Web of Science ®Google Scholar
• Clara JA, Monge C, Yang Y, Takebe N. 2020. Targeting signalling pathways and the immune microenvironment of cancer stem cells: a clinical update. Nat Rev Clin Oncol 17:204–232. https://doi.org/10.1038/s41571-019-0293-2.
   PubMed Web of Science ®Google Scholar
• Tai D, Wells K, Arcaroli J, Vanderbilt C, Aisner DL, Messersmith WA, Lieu CH. 2015. Targeting the WNT signaling pathway in cancer therapeutics. Oncologist 20:1189–1198. https://doi.org/10.1634/theoncologist.2015-0057.
   PubMed Web of Science ®Google Scholar
• Rigiracciolo DC, Nohata N, Lappano R, Cirillo F, Talia M, Scordamaglia D, Gutkind JS, Maggiolini M. 2020. IGF-1/IGF-1R/FAK/YAP transduction signaling prompts growth effects in triple-negative breast cancer (TNBC) cells. Cells 9:1010. https://doi.org/10.3390/cells9041010.
   PubMed Web of Science ®Google Scholar
• Bao B, Prasad AS. 2019. Targeting CSC in a most aggressive subtype of breast cancer TNBC. Adv Exp Med Biol 1152:311–334. https://doi.org/10.1007/978-3-030-20301-6_17.
   PubMed Web of Science ®Google Scholar
• Nagini S. 2017. Breast cancer: current molecular therapeutic targets and new players. Anticancer Agents Med Chem 17:152–163. https://doi.org/10.2174/1871520616666160502122724.
   PubMed Web of Science ®Google Scholar
• Tang J, Li Y, Sang Y, Yu B, Lv D, Zhang W, Feng H. 2018. LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling. Oncogene 37:4723–4734. https://doi.org/10.1038/s41388-018-0310-4.
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang N, Song P, Fu Y, Ren Y, Li Z, Wang J. 2020. LncRNA GATA3-AS1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L1. Cell Prolif 53:e12855. https://doi.org/10.1111/cpr.12855.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhou Y, Mao F, Lin Y, Shen S, Sun Q. 2020. lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression. Sci Rep 10:7662. https://doi.org/10.1038/s41598-020-64713-x.
   PubMed Web of Science ®Google Scholar
• Xing Z, Li S, Liu Z, Zhang C, Bai Z. 2020. CTCF-induced upregulation of HOXA11-AS facilitates cell proliferation and migration by targeting miR-518b/ACTN4 axis in prostate cancer. Prostate 80:388–398. https://doi.org/10.1002/pros.23953.
   PubMed Web of Science ®Google Scholar
• Liu L, Yan C, Tao S, Wang H. 2020. Circ_0058124 aggravates the progression of papillary thyroid carcinoma by activating LMO4 expression via targeting miR-370-3p. Cancer Manag Res 12:9459–9470. https://doi.org/10.2147/CMAR.S271778.
   PubMed Web of Science ®Google Scholar
• Sen R, Ghosal S, Das S, Balti S, Chakrabarti J. 2014. Competing endogenous RNA: the key to posttranscriptional regulation. ScientificWorldJournal 2014:896206. https://doi.org/10.1155/2014/896206.
   PubMedGoogle Scholar
• Tay Y, Rinn J, Pandolfi PP. 2014. The multilayered complexity of ceRNA crosstalk and competition. Nature 505:344–352. https://doi.org/10.1038/nature12986.
   PubMed Web of Science ®Google Scholar
• Niu L, Zhou Y, Zhang W, Ren Y. 2019. Long noncoding RNA LINC00473 functions as a competing endogenous RNA to regulate MAPK1 expression by sponging miR-198 in breast cancer. Pathol Res Pract 215:152470. https://doi.org/10.1016/j.prp.2019.152470.
   PubMed Web of Science ®Google Scholar
• Zheng P, Dong L, Zhang B, Dai J, Zhang Y, Wang Y, Qin S. 2019. Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19. Histochem Cell Biol 152:281–291. https://doi.org/10.1007/s00418-019-01794-4.
   PubMed Web of Science ®Google Scholar
• Sun X, Wang G, Ding P, Li S. 2020. LINC00355 promoted the progression of lung squamous cell carcinoma through regulating the miR-466/LYAR axis. Braz J Med Biol Res 53:e9317. https://doi.org/10.1590/1414-431X20209317.
   PubMed Web of Science ®Google Scholar
• Wang N, Hao F, Ren J, Fei X, Chen Y, Xu W, Wang J. 2020. Positive feedback loop of AKR1B10P1/miR-138/SOX4 promotes cell growth in hepatocellular carcinoma cells. Am J Transl Res 12:5465–5480.
   PubMed Web of Science ®Google Scholar
• Dong N, Guo J, Han S, Bao L, Diao Y, Lin Z. 2019. Positive feedback loop of lncRNA HOXC-AS2/miR-876-5p/ZEB1 to regulate EMT in glioma. Onco Targets Ther 12:7601–7609. https://doi.org/10.2147/OTT.S216134.
   PubMed Web of Science ®Google Scholar
• Ye X, Chen X. 2019. miR-149-5p inhibits cell proliferation and invasion through targeting GIT1 in medullary thyroid carcinoma. Oncol Lett 17:372–378. https://doi.org/10.3892/ol.2018.9628.
   PubMed Web of Science ®Google Scholar
• Xu RD, Feng F, Yu XS, Liu ZD, Lao LF. 2018. miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma. Int J Immunopathol Pharmacol 32:2058738418786656. https://doi.org/10.1177/2058738418786656.
   Web of Science ®Google Scholar
• Qi C, Qin X, Zhou Z, Wang Y, Yang Q, Liao T. 2020. Circ_0072995 promotes cell carcinogenesis via up-regulating miR-149-5p-mediated SHMT2 in breast cancer. Cancer Manag Res 12:11169–11181. https://doi.org/10.2147/CMAR.S272274.
   PubMed Web of Science ®Google Scholar
• Nusse R, Clevers H. 2017. Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell 169:985–999. https://doi.org/10.1016/j.cell.2017.05.016.
   PubMed Web of Science ®Google Scholar
• Zhang M, Weng W, Zhang Q, Wu Y, Ni S, Tan C, Xu M, Sun H, Liu C, Wei P, Du X. 2018. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5. J Hematol Oncol 11:113. https://doi.org/10.1186/s13045-018-0656-7.
   PubMed Web of Science ®Google Scholar
• Yu J, Han Z, Sun Z, Wang Y, Zheng M, Song C. 2018. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway. J Exp Clin Cancer Res 37:222. https://doi.org/10.1186/s13046-018-0896-y.
   PubMed Web of Science ®Google Scholar
• Xu M, Chen X, Lin K, Zeng K, Liu X, Xu X, Pan B, Xu T, Sun L, He B, Pan Y, Sun H, Wang S. 2019. lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer. J Hematol Oncol 12:3–3. https://doi.org/10.1186/s13045-018-0690-5.
   PubMed Web of Science ®Google Scholar
• Han C, Fu Y, Zeng N, Yin J, Li Q. 2020. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis. Aging (Albany NY) 12:3594–3616. https://doi.org/10.18632/aging.102832.
   PubMedGoogle Scholar
• Chen J-F, Wu P, Xia R, Yang J, Huo X-Y, Gu D-Y, Tang C-J, De W, Yang F. 2018. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy. Mol Cancer 17:6–6. https://doi.org/10.1186/s12943-017-0756-y.
   PubMed Web of Science ®Google Scholar
• Wang SM, Pang J, Zhang KJ, Zhou ZY, Chen FY. 2021. lncRNA MIR503HG inhibits cell proliferation and promotes apoptosis in TNBC cells via the miR-224-5p/HOXA9 axis. Mol Ther Oncolytics 21:62–73. https://doi.org/10.1016/j.omto.2021.03.009.
   PubMed Web of Science ®Google Scholar
• Devgan V, Harris A, Jiang Q, Pattison S. Cignal Reporter assay kit: A high-performance tool for assessing the functions of genes, biologics, and small molecule compounds. Qiagen, Frederick, MD.
   Google Scholar
• Zheng A, Song X, Zhang L, Zhao L, Mao X, Wei M, Jin F. 2019. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway. J Exp Clin Cancer Res 38:305. https://doi.org/10.1186/s13046-019-1315-8.
   PubMed Web of Science ®Google Scholar